Clinical Trial Update: WEgovy Real World Assessment of Weight Loss in Korea

View source ↗

Summary

This document reports a real-world assessment trial of Wegovy (semaglutide) for weight loss in Korea, sponsored by Novo Nordisk A/S. The study is currently enro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• WEGOVY (Semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity | Status: ENROLLING_BY_INVITATION